Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1Gynecologic 1CNS 1

Conditions

Glioblastoma 82Glioma 66Brain Neoplasms 60Neuroblastoma 14Astrocytoma 14Neoplasms 10Medulloblastoma 9Oligodendroglioma 8Gliosarcoma 8Breast Neoplasms 8Meningioma 7Diffuse Intrinsic Pontine Glioma 7Central Nervous System Neoplasms 7Sarcoma 6Recurrence 6Neoplasm Metastasis 6Melanoma 6Lung Neoplasms 6Ependymoma 6Osteosarcoma 4Neuroma, Acoustic 4Lymphoma, Follicular 4Squamous Cell Carcinoma of Head and Neck 3Rhabdoid Tumor 3Prostatic Neoplasms 3Pheochromocytoma 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neurofibromatosis 2 3Lymphoma 3

Interventions

montelukast 1Tablets 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Inflammation × CNS × Clear all
NCT06887673 2025-03-20

Lipid Mediators & Cancer: Montelukast, SPM, and Almonds

University of South Florida

Phase EARLY_PHASE1 Not yet recruiting
56 enrolled
CNSGastrointestinalGynecologicSarcoma

Brain Neoplasms, Inflammation, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡